Paper36836166
Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy.
Leone GM and 4 others. J Clin Med, 2023. Cited by 147 papers, by iCite.
Cite this record
ConductScience Library. Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy. Papers, record 36836166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36836166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References191
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34594000 | The blood-brain barrier in systemic infection and inflammation. | Cell Mol Immunol | 2021 | https://conductscience.org/library/papers/34594000 | PubMed |
| 2 | 17636564 | Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents. | Inflamm Bowel Dis | 2007 | https://conductscience.org/library/papers/17636564 | PubMed |
| 3 | 25624856 | Tumor necrosis factor inhibitors - state of knowledge. | Arch Med Sci | 2014 | https://conductscience.org/library/papers/25624856 | PubMed |
| 4 | 28983798 | Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience. | Adv Ther | 2017 | https://conductscience.org/library/papers/28983798 | PubMed |
| 5 | 9836088 | Infliximab approved for use in Crohn's disease: a report on the FDA GI Advisory Committee conference. | Inflamm Bowel Dis | 1998 | https://conductscience.org/library/papers/9836088 | PubMed |
| 6 | 32682491 | Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series. | Lancet | 2020 | https://conductscience.org/library/papers/32682491 | PubMed |
| 7 | 31892912 | Etiology and Management of Lack or Loss of Response to Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease. | Gastroenterol Hepatol (N Y) | 2019 | https://conductscience.org/library/papers/31892912 | PubMed |
| 8 | 12894133 | Etanercept: An overview. | J Am Acad Dermatol | 2003 | https://conductscience.org/library/papers/12894133 | PubMed |
| 9 | 34937767 | Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis. | Gut | 2021 | https://conductscience.org/library/papers/34937767 | PubMed |
| 10 | 35817469 | Tumour necrosis factor inhibitor use during pregnancy is associated with increased birth weight of rheumatoid arthritis patients' offspring. | Ann Rheum Dis | 2022 | https://conductscience.org/library/papers/35817469 | PubMed |
| 11 | 15673801 | Etanercept plus standard therapy for Wegener's granulomatosis. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15673801 | PubMed |
| 12 | 31173761 | Considerations for the Design of Antibody-Based Therapeutics. | J Pharm Sci | 2020 | https://conductscience.org/library/papers/31173761 | PubMed |
| 13 | 20694021 | Research and development of next generation of antibody-based therapeutics. | Acta Pharmacol Sin | 2010 | https://conductscience.org/library/papers/20694021 | PubMed |
| 14 | 24092417 | Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials. | Ann Rheum Dis | 2015 | https://conductscience.org/library/papers/24092417 | PubMed |
| 15 | 8502296 | Naturally occurring antibodies devoid of light chains. | Nature | 1993 | https://conductscience.org/library/papers/8502296 | PubMed |
| 16 | 1172191 | Continuous cultures of fused cells secreting antibody of predefined specificity. | Nature | 1975 | https://conductscience.org/library/papers/1172191 | PubMed |
| 17 | 31744825 | Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al. | Ann Rheum Dis | 2021 | https://conductscience.org/library/papers/31744825 | PubMed |
| 18 | 30539472 | Humanization and Simultaneous Optimization of Monoclonal Antibody. | Methods Mol Biol | 2019 | https://conductscience.org/library/papers/30539472 | PubMed |
| 19 | 22473917 | 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. | Arthritis Care Res (Hoboken) | 2012 | https://conductscience.org/library/papers/22473917 | PubMed |
| 20 | 35663580 | Neuroinflammation: A Possible Link Between Chronic Vascular Disorders and Neurodegenerative Diseases. | Front Aging Neurosci | 2022 | https://conductscience.org/library/papers/35663580 | PubMed |
Cited by103
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 147 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943631 | Akkermansia Muciniphila Attenuates TNF-α-Induced Injury in Human Primary Colonic Epithelial Cells with Ferroptosis-Associated Redox Remodeling. | Microorganisms | 2026 | https://conductscience.org/library/papers/42943631 | PubMed |
| 42851938 | Immunometabolic programming of macrophages and tumor-associated macrophages: metabolic pathways shaping polarization, immune regulation, and disease outcomes. | Front Immunol | 2026 | https://conductscience.org/library/papers/42851938 | PubMed |
| 42771292 | Compound Kushen Injection Alleviates Experimental Colitis in Mice by Regulating Macrophage Polarization through TLR4/NF-κB Signaling. | Chin J Integr Med | 2026 | https://conductscience.org/library/papers/42771292 | PubMed |
| 42769547 | Advances in tumor necrosis factor-α inhibitors for the treatment of juvenile idiopathic arthritis-associated uveitis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42769547 | PubMed |
| 42730326 | Neuroimmune Interactions in Inflammatory Skin and Intestinal Diseases. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42730326 | PubMed |
| 42638887 | Glucolipid metabolic dysfunction in ankylosing spondylitis: inflammatory mechanisms, immune-metabolic crosstalk and therapeutic implications of natural products and traditional Chinese medicine. | Front Immunol | 2026 | https://conductscience.org/library/papers/42638887 | PubMed |
| 42592597 | A reproducible pretreatment mucosal-inflammatory-remodeling state is associated with induction-phase anti-tumor necrosis factor non-response in ulcerative colitis. | Front Genet | 2026 | https://conductscience.org/library/papers/42592597 | PubMed |
| 42589362 | The Redox-Inflammation Axis in Atherosclerosis and Ischemic Stroke: Mechanisms, Biomarkers, and Translational Challenges. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589362 | PubMed |
| 42461320 | Integrated Necroptosis Within Programmed Cell Death in Traumatic Brain Injury. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42461320 | PubMed |
| 42303792 | Biologic immunomodulators and spinal fusion: evidence, mechanisms, and perioperative considerations. | Eur Spine J | 2026 | https://conductscience.org/library/papers/42303792 | PubMed |
| 42131412 | Tumor necrosis factor-alpha-mediated inflammatory bone loss: Pathogenic mechanisms and therapeutic potential of its inhibitors. | Tzu Chi Med J | 2026 | https://conductscience.org/library/papers/42131412 | PubMed |
| 42110595 | The importance of TNF-α signaling: a potential risk factor in neurodegenerative and cardiovascular diseases. | Arch Med Sci | 2026 | https://conductscience.org/library/papers/42110595 | PubMed |
| 41931245 | Evaluation of the efficacy of various hepatitis B dosage regimens in spondyloarthritis patients undergoing immunomodulatory treatment. | Clin Rheumatol | 2026 | https://conductscience.org/library/papers/41931245 | PubMed |
| 41908154 | Promising TNF-α inhibitors: Targeting pathogenic TNF-α/TNFR signaling to restore Th17/Treg balance in rheumatoid arthritis. | J Pharm Anal | 2026 | https://conductscience.org/library/papers/41908154 | PubMed |
| 41832732 | Rheumatoid Arthritis Management: Emerging Drug Therapies and Innovations. | Curr Drug Targets | 2026 | https://conductscience.org/library/papers/41832732 | PubMed |
| 41822736 | The continuing value of mesalazine as first-line therapy for patients with moderately active ulcerative colitis. | Front Gastroenterol (Lausanne) | 2024 | https://conductscience.org/library/papers/41822736 | PubMed |
| 41809609 | Adalimumab Therapy for Crohn's Disease and Axial Spondyloarthritis in Latent Tuberculosis: A bibliometric-systematic literature review. | Sultan Qaboos Univ Med J | 2026 | https://conductscience.org/library/papers/41809609 | PubMed |
| 41640516 | Co-occurrence of Vogt-Koyanagi-Harada disease, diabetic retinopathy, and advanced chronic kidney disease: a case report. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41640516 | PubMed |
| 41632348 | A comprehensive analysis of epigenetic mechanisms regulating inflammation-induced TNF-α gene expression by small-molecule inhibitor screening. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41632348 | PubMed |
| 41611908 | TWEAK receptor (Fn14) exacerbates TNF-α-induced inflammation in rheumatoid arthritis synovial fibroblasts and influences response to anti-TNF-α therapy. | Cell Mol Immunol | 2026 | https://conductscience.org/library/papers/41611908 | PubMed |
Genes47
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36836166
GET https://conductscience.org/api/papers/v1/36836166/references?page=2